Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.

Seethalakshmi L, Mitra SP, Dobner PR, Menon M, Carraway RE.

Prostate. 1997 May 15;31(3):183-92.

PMID:
9167771
[PubMed - indexed for MEDLINE]
2.

Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.

Iwase K, Evers BM, Hellmich MR, Kim HJ, Higashide S, Gully D, Thompson JC, Townsend CM Jr.

Cancer. 1997 May 1;79(9):1787-93.

PMID:
9128997
[PubMed - indexed for MEDLINE]
3.

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.

Amorino GP, Deeble PD, Parsons SJ.

Oncogene. 2007 Feb 1;26(5):745-56. Epub 2006 Jul 24.

PMID:
16862179
[PubMed - indexed for MEDLINE]
4.

Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.

Carraway RE, Hassan S, Cochrane DE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):93-107. Epub 2006 Jan 6.

PMID:
16406549
[PubMed - indexed for MEDLINE]
5.

Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress.

Carraway RE, Hassan S.

Regul Pept. 2007 Jun 7;141(1-3):140-53. Epub 2007 Jan 16.

PMID:
17289170
[PubMed - indexed for MEDLINE]
6.

Relevant genomics of neurotensin receptor in cancer.

Elek J, Pinzon W, Park KH, Narayanan R.

Anticancer Res. 2000 Jan-Feb;20(1A):53-8.

PMID:
10769634
[PubMed - indexed for MEDLINE]
7.

Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines.

Almeida TA, Rodriguez Y, Hernández M, Reyes R, Bello AR.

Peptides. 2010 Feb;31(2):242-7. doi: 10.1016/j.peptides.2009.12.007. Epub 2009 Dec 14.

PMID:
20018219
[PubMed - indexed for MEDLINE]
8.

Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.

Carraway RE, Hassan S, Dobner PR.

Regul Pept. 2008 Apr 10;147(1-3):96-109. doi: 10.1016/j.regpep.2008.01.009. Epub 2008 Feb 11.

PMID:
18313772
[PubMed - indexed for MEDLINE]
9.

Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.

Carraway RE, Gui X, Cochrane DE.

J Pharmacol Exp Ther. 2003 Nov;307(2):640-50. Erratum in: J Pharmacol Exp Ther. 2004 Apr;309(1):439.

PMID:
14570823
[PubMed - indexed for MEDLINE]
Free Article
10.

Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.

Sehgal I, Powers S, Huntley B, Powis G, Pittelkow M, Maihle NJ.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4673-7.

PMID:
8197117
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.

Jiang J, Sugimoto Y, Liu S, Chang HL, Park KY, Kulp SK, Lin YC.

Anticancer Res. 2004 Jan-Feb;24(1):91-100.

PMID:
15015581
[PubMed - indexed for MEDLINE]
Free Article
12.

SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.

Moody TW, Chiles J, Casibang M, Moody E, Chan D, Davis TP.

Peptides. 2001 Jan;22(1):109-15.

PMID:
11179604
[PubMed - indexed for MEDLINE]
13.
14.

LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.

Esquenet M, Swinnen JV, Heyns W, Verhoeven G.

J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):391-9.

PMID:
9449242
[PubMed - indexed for MEDLINE]
15.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
[PubMed - indexed for MEDLINE]
16.

Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.

Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF.

Carcinogenesis. 2001 Nov;22(11):1765-73.

PMID:
11698337
[PubMed - indexed for MEDLINE]
Free Article
17.

Human umbilical vein endothelial cells express high affinity neurotensin receptors coupled to intracellular calcium release.

Schaeffer P, Laplace MC, Savi P, Pflieger AM, Gully D, Herbert JM.

J Biol Chem. 1995 Feb 17;270(7):3409-13.

PMID:
7852427
[PubMed - indexed for MEDLINE]
Free Article
18.

Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.

Dal Farra C, Sarret P, Navarro V, Botto JM, Mazella J, Vincent JP.

Int J Cancer. 2001 May 15;92(4):503-9.

PMID:
11304684
[PubMed - indexed for MEDLINE]
19.

Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor.

Grigoryev DN, Long BJ, Njar VC, Brodie AH.

J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):1-10.

PMID:
11179903
[PubMed - indexed for MEDLINE]
20.

Expression of neurotensin receptors in human corneal keratocytes.

Bourcier T, Rondeau N, Paquet S, Forgez P, Lombet A, Pouzaud F, Rostène W, Borderie V, Laroche L.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1765-71.

PMID:
12036977
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk